Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) EBIT Margin (2020 - 2025)

Historic EBIT Margin for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 91.78%.

  • SOPHiA GENETICS's EBIT Margin rose 51300.0% to 91.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 95.28%, marking a year-over-year increase of 102800.0%. This contributed to the annual value of 102.14% for FY2024, which is 178300.0% up from last year.
  • SOPHiA GENETICS's EBIT Margin amounted to 91.78% in Q3 2025, which was up 51300.0% from 100.92% recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's EBIT Margin peaked at 90.2% during Q1 2025, and registered a low of 230.37% during Q1 2022.
  • For the 5-year period, SOPHiA GENETICS's EBIT Margin averaged around 138.49%, with its median value being 118.87% (2024).
  • In the last 5 years, SOPHiA GENETICS's EBIT Margin crashed by -738000bps in 2022 and then soared by 1014700bps in 2023.
  • Over the past 5 years, SOPHiA GENETICS's EBIT Margin (Quarter) stood at 192.09% in 2021, then soared by 41bps to 112.69% in 2022, then increased by 1bps to 111.13% in 2023, then rose by 11bps to 98.37% in 2024, then grew by 7bps to 91.78% in 2025.
  • Its EBIT Margin stands at 91.78% for Q3 2025, versus 100.92% for Q2 2025 and 90.2% for Q1 2025.